Identifying allergies in the context of atopic dermatitis is important not only for treating the disease, but early treatment with immunotherapy – both allergy drops and shots – has been shown to alter the atopic march.
Allergic asthma, in particular, responds especially well to sublingual immunotherapy. Research suggests it can be prevented in many children when immunotherapy begins with an early atopic dermatitis/allergy diagnosis.
Controlled studies have shown that allergic children treated with sublingual immunotherapy had a significantly lower risk of developing asthma than children who were not treated at all with sublingual immunotherapy. Airborne and food allergies are typically at the root of the problem, and their contribution to allergic inflammation can be blocked and even reversed when sublingual immunotherapy starts at an early age.